Building upon the success of last year's Stories of Women-Led Innovation Event, this forum continued highlighting the achievements and challenges faced by our women innovators and demystifying the innovation pathway through presentations and panel discussions. Sessions covered intellectual property protection, building inclusive teams and addressing bias in the context of academic innovation.
Attendees were excited to hear from our keynote speaker, Gitanjali Rao, aspiring scientist, inventor and author!
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
This event aimed to educate and inspire entrepreneurs at all stages. Featuring panels on company formation, funding biomedical discoveries and creating strategic alliances, each session included interactive elements and the chance to network with potential partners from the Anschutz campus and beyond.
Attendees got to know Jodie Morrison, CEO of Q32 Bio, and Kimberly Muller, Executive Director of CU Innovations, through their Fireside Chat Keynote.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
Congratulations to the judge vote winner, NowVitals pitched by Robin Deterding, MD, and the audience vote winner, Vināśa Oncology pitched by Sujatha Venkataraman, PhD!
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
With sessions featuring scientific talks, career panels, and a 2-hour networking lunch, RMBTS offered a prime platform to highlight scientific advancements and career opportunities, and foster collaboration within Colorado's scientific community.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
I earned my PhD in Emerging Infectious Diseases from the Uniformed Services University in Bethesda, MD, and an MS in Biochemistry from the University of Maryland at Baltimore. I spent close to 10 years as an Assistant Professor in the Department of Pediatrics-Infectious Diseases at the University of Colorado, where I led a research program focused on varicella-zoster virus pathogenesis. Since transitioning to the pharmaceutical industry, I have devoted most of my time to being a Medical Science Liaison supporting the vaccine portfolios at GSK, Sanofi and Takeda. Currently, I am a Senior MSL on the Epilepsy team at Takeda.
PLATINUM SPONSORS:
SPONSORS: